...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM - Jan 7, 2016 - Details
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Hi longtimerzen.

I guess I don't know the history very much beyond 8 years ago. Did RVX take over a company to get a TSX listing? I had just assumed they applied for and paid for the TSX listing.

Please let me know the background.

Regards

Toinv

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply